BackEventide Healthcare & Life Sciences Fd Cl I Overview
Eventide Healthcare & Life Sciences Fd Cl I

Eventide Healthcare & Life Sciences Fd Cl I Return on Equity

Eventide Healthcare & Life Sciences Fd Cl I (ETIHX) has a ROE of -3.73%, below the sector sector average of 11.85%.

Get informed when a big investor buys or sells

+ Follow

ROE

-3.73%

Return on Equity

-3.73%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Eventide Healthcare & Life Sciences Fd Cl I (ETIHX) FAQ

Eventide Healthcare & Life Sciences Fd Cl I posts a ROE of -3.73%. That is below the sector sector average of 11.85%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near 11.85% is typical. Eventide Healthcare & Life Sciences Fd Cl I's -3.73% is lower that level. That is roughly 131.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Eventide Healthcare & Life Sciences Fd Cl I's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -3.73%; use YoY and peer views to separate noise from signal.

Context for ETIHX's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.85%), and (3) consistency with growth and profitability. This page covers the first two; Eventide Healthcare & Life Sciences Fd Cl I's other metric pages and overview cover the third.